Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-25-005177
Filing Date
2025-07-17
Accepted
2025-07-17 15:11:25
Documents
54
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR MAR 2025 stemtech_i10q-033125.htm   iXBRL 10-Q 622895
2 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER stemtech_ex3101.htm EX-31.1 10932
3 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER stemtech_ex3102.htm EX-31.2 11089
4 CERTIFICATION stemtech_ex3201.htm EX-32.1 4815
5 CERTIFICATION stemtech_ex3202.htm EX-32.2 4685
  Complete submission text file 0001683168-25-005177.txt   3716584

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE stek-20250331.xsd EX-101.SCH 33045
7 XBRL CALCULATION FILE stek-20250331_cal.xml EX-101.CAL 57459
8 XBRL DEFINITION FILE stek-20250331_def.xml EX-101.DEF 97783
9 XBRL LABEL FILE stek-20250331_lab.xml EX-101.LAB 263163
10 XBRL PRESENTATION FILE stek-20250331_pre.xml EX-101.PRE 208790
57 EXTRACTED XBRL INSTANCE DOCUMENT stemtech_i10q-033125_htm.xml XML 424612
Mailing Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103 (954) 715-6000
Stemtech Corp (Filer) CIK: 0001511820 (see all company filings)

EIN.: 872151440 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-172172 | Film No.: 251130350
SIC: 5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries
(CF Office: 07 Trade & Services)